Hypophosphatemia in kidney stone formers

Area of Science:

• Nephrology
• Genetics
• Metabolic Disorders

Background:

• Hypophosphatemia is common in kidney stone formers, but the link to nephrolithiasis is unclear.
• Phosphate metabolism is gaining attention as a risk factor and therapeutic target for kidney stones.
• This review explores disordered phosphate homeostasis in nephrolithiasis.

Purpose of the Study:

• To review the current understanding of phosphate metabolism in kidney stone disease.
• To highlight recent genetic and therapeutic developments.
• To explore the link between phosphate handling and nephrolithiasis.

Main Methods:

• Literature review of recent studies on phosphate homeostasis and nephrolithiasis.
• Analysis of genetic factors influencing phosphate transport.
• Evaluation of therapeutic strategies, including phosphate supplementation.

Main Results:

• Kidney stone formers show low serum phosphate and high kidney phosphate loss, mainly from reduced tubular reabsorption.
• Genetic variants in proximal tubule phosphate transporters are implicated in this phenomenon.
• Phosphate supplementation can reduce urinary calcium and prevent stone recurrence, though responses vary, possibly due to genetic differences.

Conclusions:

• Understanding tubular phosphate handling and genetics in nephrolithiasis is crucial.
• Genetic screening and personalized therapies, like phosphate supplementation, can improve outcomes.
• Research on transporter variants and clinical outcomes points to individualized stone therapy.